Picture of Phathom Pharmaceuticals logo

PHAT — Phathom Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Phathom Pharmaceuticals Provides Regulatory Updates

Feb 9 (Reuters) - Phathom Pharmaceuticals Inc  PHAT.O :
    * PHATHOM PHARMACEUTICALS PROVIDES REGULATORY UPDATES
    * PHATHOM PHARMA - ANNOUNCED REGULATORY UPDATES FOR ITS
APPROVED
PRODUCTS, VOQUEZNA TRIPLE PAK AND VOQUEZNA DUAL PAK, & ITS
PENDING NDA FOR VONOPRAZAN
    * PHATHOM PHARMA - HAS RECEIVED COMPLETE RESPONSE LETTERS
FROM FDA
RELATING TO EROSIVE ESOPHAGITIS NDA AND H. PYLORI POST APPROVAL
SUPPLEMENT
    * PHATHOM-EXPECTS TO MEET FDA IN Q1 TO DISCUSS RESUBMISSION
PLAN,TIMELINE THAT CO BELIEVES WILL LEAD TO APPROVAL,LAUNCH OF
PRODUCTS CONTAINING VONOPRAZAN

Source text for Eikon:  ID:nGNX3x696C 
Further company coverage:  PHAT.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Phathom Pharmaceuticals

See all news